{"address1": "Times Square Tower", "address2": "Suite 2503 7 Times Square", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "646 200 5278", "website": "https://www.sellaslifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Dr. Angelos M. Stergiou M.D., ScD h.c.", "age": 48, "title": "Founder, President, CEO & Director", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 904243, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Thomas Burns CPA", "age": 39, "title": "Senior VP & CFO", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 505158, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy E. Yeung", "title": "VP of Legal Affairs, Head of Compliance & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dragan  Cicic M.D., MBA", "age": 61, "title": "Senior Vice President of Clinical Development", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 466430, "exercisedValue": 0, "unexercisedValue": 55739}, {"maxAge": 1, "name": "Mr. Andrew  Elnatan", "title": "Senior VP of Regulatory Affairs, CMC & Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.08, "open": 1.08, "dayLow": 1.05, "dayHigh": 1.11, "regularMarketPreviousClose": 1.08, "regularMarketOpen": 1.08, "regularMarketDayLow": 1.05, "regularMarketDayHigh": 1.11, "payoutRatio": 0.0, "beta": 2.435, "forwardPE": -2.5348837, "volume": 1133376, "regularMarketVolume": 1133376, "averageVolume": 2575443, "averageVolume10days": 918160, "averageDailyVolume10Day": 918160, "bid": 1.06, "ask": 1.1, "bidSize": 9, "askSize": 9, "marketCap": 99022912, "fiftyTwoWeekLow": 0.77, "fiftyTwoWeekHigh": 1.84, "fiftyDayAverage": 1.2258, "twoHundredDayAverage": 1.1853, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 86137896, "profitMargins": 0.0, "floatShares": 90562342, "sharesOutstanding": 90846704, "sharesShort": 7845644, "sharesShortPriorMonth": 8652314, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0998, "heldPercentInsiders": 0.00133, "heldPercentInstitutions": 0.0682, "shortRatio": 7.26, "shortPercentOfFloat": 0.1, "impliedSharesOutstanding": 90846704, "bookValue": 0.128, "priceToBook": 8.515625, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -30881000, "trailingEps": -0.5, "forwardEps": -0.43, "lastSplitFactor": "1:50", "lastSplitDate": 1573171200, "52WeekChange": -0.16793895, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.09, "targetHighPrice": 7.5, "targetLowPrice": 4.0, "targetMeanPrice": 5.83333, "targetMedianPrice": 6.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 13886000, "totalCashPerShare": 0.153, "totalDebt": 1001000, "quickRatio": 1.46, "currentRatio": 1.717, "debtToEquity": 10.576, "returnOnAssets": -1.5356599, "returnOnEquity": -41.478836, "freeCashflow": -24253624, "operatingCashflow": -35402000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 0.925925, "regularMarketPrice": 1.09, "marketState": "PRE", "shortName": "SELLAS Life Sciences Group, Inc", "longName": "SELLAS Life Sciences Group, Inc.", "corporateActions": [], "preMarketTime": 1743596659, "regularMarketTime": 1743537601, "exchange": "NCM", "messageBoardId": "finmb_262231850", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "preMarketChange": 0.00999999, "preMarketChangePercent": 0.9174303, "preMarketPrice": 1.1, "regularMarketChange": 0.00999999, "regularMarketDayRange": "1.05 - 1.11", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2575443, "fiftyTwoWeekLowChange": 0.32000005, "fiftyTwoWeekLowChangePercent": 0.4155845, "fiftyTwoWeekRange": "0.77 - 1.84", "fiftyTwoWeekHighChange": -0.75, "fiftyTwoWeekHighChangePercent": -0.4076087, "fiftyTwoWeekChangePercent": -16.793896, "dividendDate": 1573171200, "earningsTimestamp": 1742501101, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.5, "epsForward": -0.43, "epsCurrentYear": -0.42333, "priceEpsCurrentYear": -2.5748234, "fiftyDayAverageChange": -0.1358, "fiftyDayAverageChangePercent": -0.11078479, "twoHundredDayAverageChange": -0.09529996, "twoHundredDayAverageChangePercent": -0.080401555, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1205328600000, "displayName": "SELLAS Life Sciences", "trailingPegRatio": null}